Reply to: Optimal dosing and duration of linezolid in multidrug-resistant tuberculosis: methodological and clinical appraisal.

Kwak, N., Kim, J.-Y., Han, A., Hahn, S., & Yim, J.-J. (2026). Reply to: Optimal dosing and duration of linezolid in multidrug-resistant tuberculosis: methodological and clinical appraisal.. The European Respiratory Journal, 67(1).